Feel30 TRT Review – The Injection Is Approved, the Pill Is Not

What Feel30 Is and Who It Is For

Feel30 is a US telehealth clinic selling testosterone replacement therapy to men, with injectable testosterone cypionate, an oral option and enclomiphene. Its distinguishing feature is a concierge nurse who comes to your home for quarterly blood work — which, as we will explain, is the genuinely good idea here.

Pricing is $149 a month on an annual plan, $189 on six months, or $229 rolling, with bloodwork, consultations and shipping stated as included.

This article is informational only and is not medical advice. Testosterone is a Schedule III controlled substance, and whether you need it is a question for a clinician with your blood results in front of them. All details checked 8 August 2026.

Where You Cannot Get It

Worth establishing first, because it saves some readers the rest of the page. The programme is not available in:

Sixteen states, and the list includes some large ones. US only, and check your state before starting an intake.

We Checked Both Drugs Against the FDA Database

Rather than take anyone’s word for regulatory status, we queried the FDA’s own Drugs@FDA database for each product. The results are the most useful thing in this review, and they run opposite to most people’s intuition.

We ran the clomiphene and testosterone queries specifically to prove the search works, because an empty result from a broken query proves nothing. Both returned results using the identical query form, so the enclomiphene zero is a real finding rather than a failed lookup.

Credit where it is due on the injectable. After a run of reviews covering compounded GLP-1s and research-labelled peptides, a telehealth service dispensing an actually approved drug is a meaningful step up — approved products have known manufacturing standards, a real label and an established evidence base.

The enclomiphene page never claims FDA approval — but it never discloses the absence either. It says medications are “manufactured in registered US facilities”, and registration is a statement about a facility, not approval of a product. We would rather see that stated outright, as some competitors do.

The Fertility Warning Is on the Wrong Page

This is the most important finding in this review, and it is entirely internal to Feel30’s own website.

On the enclomiphene page, they state the risk clearly and accurately:

On the testosterone cypionate page, the safety section lists: prostate cancer, breast cancer, uncontrolled heart failure, untreated sleep apnoea, heart disease, kidney disease, liver disease.

So the effect on fertility — arguably the single most consequential thing a younger man should know before starting testosterone — appears only where it functions as a selling point for the other product.

We are not suggesting anyone is hiding it. The company clearly knows the fact, states it correctly, and sells the fertility-sparing alternative alongside. The problem is placement. A man who lands directly on the testosterone cypionate page, reads the safety section, and buys an annual plan is never told.

If there is one thing to take from this page: if you might want children — now, later, or you are not sure — raise fertility explicitly with the prescribing clinician before you start testosterone. Ask about sperm banking beforehand, and ask whether enclomiphene is more appropriate for you. That conversation is much easier to have before treatment than after.

The Page Contradicts Itself About Blood Work

Baseline blood work is the central safeguard in TRT. Low testosterone is diagnosed from measured levels plus symptoms, not from symptoms alone — because fatigue, low mood, poor sleep and low libido have many causes, most of which testosterone will not fix.

The same product page says both of these:

Both cannot be true. Our honest reading is that this is duplicated template copy — the phrase appears in a generic feature block that also shows up in a slightly different form higher on the page, and “no labs needed” would be accurate for their erectile dysfunction products.

The rest of the business only makes sense if labs are required — they are selling a concierge phlebotomy service as their core differentiator. You do not build that if you do not draw blood.

The Concierge Lab Service Is the Best Idea Here

Having been critical, this deserves real praise, because it addresses a genuine clinical problem rather than an invented one.

TRT is not a set-and-forget treatment. It requires ongoing monitoring, and the well-known failure mode of online hormone clinics is that patients get the prescription indefinitely and the follow-up bloods never happen — because booking a lab visit is a small friction that people simply do not overcome.

Sending a nurse to the patient’s home for quarterly draws attacks exactly that failure, and the company is straightforward about why: “This removes the #1 barrier in TRT: lab compliance.” That is an accurate diagnosis of the problem and a sensible solution to it.

Bundling the labs into the price rather than billing per draw reinforces it — there is no per-test charge to discourage you from getting monitored. Structurally, that is the right incentive, and it is better than several larger competitors manage.

What the Safety Section Covers, and One Omission

The contraindication list is better than many telehealth pages bother with. It names prostate and breast cancer, uncontrolled heart failure, untreated sleep apnoea, and heart, kidney and liver disease, and states that the physician reviews history and tests first.

They also say they monitor “testosterone blood levels, liver function, and overall health markers.”

Two questions worth asking any TRT provider, including this one: what exactly is on the panel, and what will you do if a marker moves in the wrong direction? A provider that monitors but never adjusts is not really monitoring.

Pricing: $149 a Month Means $1,788 Up Front

The annual plan saves roughly $960 a year against paying monthly — a genuine saving, and the discount structure is normal. But read the middle column. The advertised “$149/month” is $1,788 taken up front, before your first blood draw, on a treatment you have not started and may turn out not to need.

Given that, the monthly plan is worth its premium for a first-timer. Paying $229 for a month or two while you find out whether TRT suits you costs a few hundred dollars more if you continue — and saves you well over a thousand if you do not.

In fairness, the inclusions are real and stated: bloodwork, physician consultations, express shipping, medication, and a vitamin D biomarker. A comparison block on the site puts standalone bloodwork at $387 a year and shipping at $174 — their figures, not ours, but the all-inclusive framing is at least specific.

The Money-Back Guarantee Covers Being Turned Down

The product pages advertise a “100% money-back guarantee” and “100% Risk Free.” Here is the wording underneath:

So the guarantee covers the case where they decline you — where keeping your money would be indefensible anyway. What we could not find is any guarantee covering the outcome that actually worries people: you are approved, you pay $1,788, and the treatment does not do what you hoped.

“Cancel anytime” appears alongside annual billing, and we could not establish whether cancelling an annual plan mid-term produces a pro-rata refund. Ask that question before you choose the annual tier, because it is the difference between a $229 decision and a $1,788 one.

One Line of Copy Worth Pausing On

That sentence diagnoses the reader before anyone has measured anything.

Tiredness, low motivation, poor recovery and brain fog are real and worth taking seriously — and they are also the presenting symptoms of depression, sleep apnoea, thyroid disease, anaemia, diabetes, alcohol use and simply not sleeping enough. Some of those are more dangerous than low testosterone and none of them are improved by treating the wrong thing.

“It’s not burnout” is precisely the claim nobody can make before a blood test, and it sits oddly on a site whose better instinct is to build a service around measuring people properly.

Who Should Not Do This

• Anyone who wants children in future, until they have had the fertility conversation and considered sperm banking or enclomiphene
• Anyone with prostate or breast cancer, uncontrolled heart failure, untreated sleep apnoea, or significant heart, kidney or liver disease — the company says so too
• Anyone who has not had testosterone measured properly. Symptoms alone are not a diagnosis, and the alternative explanations are often more important
• Anyone attracted by “no labs needed.” That is the wrong reason to start a controlled substance
• Anyone who would struggle to keep up quarterly monitoring — though this is the service most likely to solve that
• Anyone in the sixteen states listed above, where it is unavailable

Common TRT side effects include acne, oily skin, fluid retention, mood changes, breast tenderness, worsening sleep apnoea and raised red blood cell counts, alongside the fertility suppression discussed above. This is not a complete list — a clinician with your history is the right source.

How It Compares

The comparison most readers should run first is against their own doctor. Testosterone deficiency is a recognised medical condition, testosterone cypionate is an approved generic, and if you have insurance, going through your physician is very often dramatically cheaper — with the advantage that someone who knows your whole history investigates the alternative explanations for your symptoms first.

Feel30’s real advantage is convenience and monitoring compliance, and for someone who has already tried and failed to keep up with lab appointments, that is worth something genuine.

Pros and Cons

Limitations of This Review

Our general web search capability was unavailable, so this review is built from Feel30’s own product pages and direct queries against the FDA’s Drugs@FDA database, which is where the approval findings come from. Those queries are the strongest evidence here and we validated them against known positives before trusting the negative.

What is missing matters. We did not check Trustpilot, the BBB, state medical board records, malpractice or complaint databases, or Reddit. We cannot tell you how the clinicians practise, how thorough the intake is, whether baseline labs are in fact required, or how the concierge draws work in reality. Those are exactly the questions this review most wanted answered. Treat their absence as unchecked, not clean.

We have not used the service. We could not confirm which manufacturer’s testosterone is dispensed, what is on the hormone panel, the clinicians’ names or credentials, or the mid-term cancellation terms. The 4.9 rating and 1,000+ reviews are self-hosted figures we could not verify, and the testimonials are first-name-only.

On the labs contradiction, we have given our honest reading — that it is template copy — rather than treating it as a policy statement. We could be wrong in either direction, which is precisely why we suggest you ask. Prices and state availability checked 8 August 2026 and change.

Nothing here is medical advice. Whether you have testosterone deficiency, and what to do about it, is a question for a clinician with your results — ideally one who does not earn money from the answer.

Frequently Asked Questions

Verdict

Feel30 gets the hardest part right. Its flagship is an actually FDA-approved medicine — we confirmed 10 approved applications for testosterone cypionate in the FDA’s own database — and its central idea, sending a nurse to your home so the follow-up bloods actually happen, targets the real failure of online hormone medicine. Bundling those labs into the price so nothing discourages monitoring is the correct incentive. That is a better foundation than most of this category has.

Which makes the gaps harder to forgive rather than easier.

Testosterone can suppress fertility. Feel30 knows this and says so accurately — on the page selling enclomiphene, where it works as a reason to buy the other product. The safety section of the testosterone page does not mention sperm or fertility at all. A man who arrives on that page and buys a year of treatment is never told. That is the single change we would most want them to make.

Then the same page tells you dosing depends on your blood work and that no labs are needed. We think that is a copy-paste error rather than a policy — the whole business model presumes blood draws — but a patient cannot tell which line is the mistake, and on a Schedule III controlled substance that ambiguity is not trivial.

And the oral option is not an approved drug. Enclomiphene returned zero results in the FDA database against 6 for clomiphene and 10 for testosterone cypionate on the identical query. The page does not claim approval, but it does not disclose the absence either — and the convenient pill being the unapproved one is exactly the thing a buyer would never guess.

If you are considering this: talk to your own doctor first, because low testosterone is a real diagnosis, the drug is an approved generic, and insurance often makes that route far cheaper than $1,788 a year. If you go with Feel30, start on the monthly plan rather than handing over a year up front, insist on baseline labs, ask what is on the panel including haematocrit, and raise fertility before your first injection rather than after.